Health Canada To Conduct Review Of A New Potential Safety Risk Of Fibristal (ulipristal Acetate), A Medication Used To Treat Fibroids

Fibristal Recall Summary Health Canada is reviewing a potential safety concern with Fibristal (ulipristal acetate), a medication used to treat uterine fibroids. The review affects all Fibristal products distributed across Canada. Health Canada is investigating this safety issue and will communicate findings as the review progresses.

Reason

Product safety

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2018-03-15

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/ba72265f-5eca-48c4-a190-95b8b3a9a37f